| « Bomb cyclone and Arctic outbreak put 215 million under weather alerts | ICE Lost Track of 150,000 Illegal Immigrants - Florida AG » |
In Rare Bipartisan Push, Lawmakers Look to Speed Up Approval of Crucial Drugs
Passage could be lifesaver for people suffering mental illness, military veteran | A bill intended to speed up federal approval of drugs and therapies that show promise in treating diseases and conditions resistant to available treatments has received a rare show of lawmaker unity. ● The Breakthrough Therapies Act is being backed by Reps. Alexandria Ocasio-Cortez (D-N.Y.) and Dan Crenshaw (R-Texas), and Sens. Cory Booker (D-N.J.) and Rand Paul (R-Ky.). ● A chief component of the bill is allowing the Drug Enforcement Agency (DEA) to reclassify substances from Schedule I to Schedule II. Schedule I substances, as defined by the DEA, are “drugs with no currently accepted medical use and a high potential for abuse.” Schedule II drugs are used medically, and also have a “high potential for abuse, with use potentially leading to severe psychological or physical dependence.” In particular, a group of Schedule I substances called psychedelics, or hallucinogens, have been demonstrated to help people suffering from mental illness—their conditions include major depression, anxiety, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). ● Psychedelics could benefit military combat veterans whose emotional experiences and physical wounds contribute to serious and debilitating mental health conditions that are resistant to, and not relieved by, available treatments.
No feedback yet
